Cytokinetics | CYTK - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
Acadia Pharmaceuticals USD 146.88M 1.69M 2026-09
Amgen USD 1.68B 40M 2026-09
Arca Biopharma USD 2.23M 1.08M 2025-12
Bayer EUR 4.02B 53M 2026-09
Biogen USD 752M 42.3M 2026-09
Brainstorm Cell Therapeutics USD 1.21M 178K 2026-03
Bristol-Myers Squibb USD 1.7B 127M 2026-09
Capricor Therapeutics USD 1.92M 446.47K 2025-12
Cytokinetics USD 113.14M 8.75M 2026-09
Eisai JPY 120.4B 5.58B 2026-09
Eli Lilly USD 3.12B 305M 2026-09
Exelixis USD 154.56M 6.93M 2026-09
Geron USD 35.7M 3.16M 2026-09
Halozyme Therapeutics USD 58.24M 1.24M 2026-09
Ionis Pharmaceuticals USD 154M 23.92M 2026-09
Ligand Pharmaceuticals USD 72.62M 43.49M 2026-09
Merck USD 2.86B 25M 2026-09
Novartis USD 3.08B 163M 2026-09
Pfizer USD 3.28B 132M 2026-09
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.31B 325M 2026-09